相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Modulation of glucagon-like peptide-1 release by berberine: In vivo and in vitro studies
Yunli Yu et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Atrogin-1 Affects Muscle Protein Synthesis and Degradation When Energy Metabolism Is Impaired by the Antidiabetes Drug Berberine
Huiling Wang et al.
DIABETES (2010)
Extensive Intestinal First-Pass Elimination and Predominant Hepatic Distribution of Berberine Explain Its Low Plasma Levels in Rats
Yi-Tong Liu et al.
DRUG METABOLISM AND DISPOSITION (2010)
Glucagon-Like Peptide-1 Receptor Is Present on Human Hepatocytes and Has a Direct Role in Decreasing Hepatic Steatosis In Vitro by Modulating Elements of the Insulin Signaling Pathway
Nitika Arora Gupta et al.
HEPATOLOGY (2010)
Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression
Hao Zhang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Hepatocyte Nuclear Factor 1α Plays a Critical Role in PCSK9 Gene Transcription and Regulation by the Natural Hypocholesterolemic Compound Berberine
Hai Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Increased carnitine palmitoyl transferase 1 expression and decreased sterol regulatory element-binding protein 1c expression are associated with reduced intramuscular triglyceride accumulation after insulin therapy in high-fat-diet and streptozotocin-induced diabetic rats
Yan Bi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin. receptor expression
Wei-Jia Kong et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Berberine improves glucose metabolism through induction of glycolysis
Jun Yin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: A mechanism for the action of berberine to activate AMP-Activated protein kinase and improve insulin action
Nigel Turner et al.
DIABETES (2008)
Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine
Yifei Zhang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Traditional Chinese Medicine in Treatment of Metabolic Syndrome
Jun Yin et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2008)
Berberine stimulates glucose transport through a mechanism distinct from insulin
Libin Zhou et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK
Zhe Cheng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2006)
Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis
Kosaku Uyeda et al.
CELL METABOLISM (2006)
Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states
Yun S. Lee et al.
DIABETES (2006)
Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine
Jean-Marie Brusq et al.
JOURNAL OF LIPID RESEARCH (2006)
Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract
XL Wang et al.
LIFE SCIENCES (2005)
Insulin sensitizing and insulinotropic action of berberine from Cortidis rhizoma
BS Ko et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
Factors that control the tissue-specific transcription of the gene for phosphoenolpyruvate carboxykinase-C
K Chakravarty et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Hypoxia-responsive transcription factors
EP Cummins et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2005)
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy
M Sandri et al.
CELL (2004)
Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase
SR Kimball et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
WJ Kong et al.
NATURE MEDICINE (2004)
Role of the liver in the control of carbohydrate and lipid homeostasis
C Postic et al.
DIABETES & METABOLISM (2004)
SREBP transcription factors:: master regulators of lipid homeostasis
D Eberlé et al.
BIOCHIMIE (2004)
The IGF-1/PI3K/Akt pathway prevents short article expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors
TN Stitt et al.
MOLECULAR CELL (2004)
Inhibition of mouse liver respiration by Chelidonium majus isoquinoline alkaloids
MC Barreto et al.
TOXICOLOGY LETTERS (2003)
Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lepob/Lepob mice
N Yahagi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
分享论文
